Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

ALKERAN (Melphallan) Tablets
Company:  Glaxo Wellcome, Inc.
Application No.:  14-691/S20
Approval Date: 5/24/2001


Date created: July 05, 2003

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.